Study ID: GA/9016 (FORTE)

Study Title

Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).

Teva Identifier

GA/9016 (FORTE)

ClinicalTrials.gov Identifier

NCT00337779

Study Status

Completed

Trial Condition(s)

Relapsing Remitting Multiple Sclerosis

Interventions

Drug: Glatiramer Acetate (GA) 40 mg | Drug: glatiramer acetate 20 mg

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 55 Years

Trial Duration

08/01/2006 - 10/01/2008

Phase

Phase 3

Study Type

Interventional